Davidson Investment Advisors lessened its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 4.5% during the second quarter, Holdings Channel.com reports. The firm owned 95,348 shares of the health services provider’s stock after selling 4,521 shares during the quarter. Cigna Group makes up 1.1% of Davidson Investment Advisors’ investment portfolio, making the stock its 25th biggest holding. Davidson Investment Advisors’ holdings in Cigna Group were worth $26,285,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of CI. Assetmark Inc. grew its stake in shares of Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after buying an additional 5,963 shares during the period. Mystic Asset Management Inc. bought a new stake in Cigna Group in the 2nd quarter valued at about $2,808,000. KBC Group NV raised its stake in Cigna Group by 6.4% during the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after buying an additional 22,978 shares during the period. Sanctuary Advisors LLC acquired a new position in Cigna Group during the 2nd quarter worth approximately $11,043,000. Finally, HighTower Advisors LLC boosted its holdings in Cigna Group by 402.7% in the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock worth $97,701,000 after acquiring an additional 283,897 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Cigna Group Price Performance
Shares of NYSE CI opened at $278.89 on Friday. The company has a market capitalization of $73.69 billion, a PE ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock’s 50 day moving average price is $283.52 and its 200-day moving average price is $281.39. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.
Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.
Insiders Place Their Bets
In related news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock worth $6,386,550 over the last quarter. Company insiders own 0.60% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have commented on CI shares. Guggenheim raised their price objective on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Piper Sandler cut their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Sanford C. Bernstein increased their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. The Goldman Sachs Group lifted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Morgan Stanley boosted their price target on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $339.45.
Check Out Our Latest Research Report on CI
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
